Matt Lasmanis

Board advisor and C-suite digital transformation leader operating at the intersection of enterprise strategy, emerging technology, and global business growth. 20+ years of experience directing high-impact technology investments that drive long-term value, operating efficiency, and market expansion for global enterprises spanning $1B to $100B+ in market capitalization.

Known for an enterprise-wide perspective that aligns technical depth with macro strategy. Proven track record guiding global enterprises through complex technological shifts across heavily regulated biopharma, biotechnology, and media sectors.

EXECUTIVE LEADERSHIP BACKGROUND
▪ Chief Digital Officer, Jazz Pharmaceuticals (NASDAQ: JAZZ) 
▪ Former Chief Technology & Innovation Officer, Sage Therapeutics (NASDAQ: SAGE) 
▪ Former VP, Chief Digital & Technology Officer (US), GlaxoSmithKline (LON / NYSE: GSK) 
▪ Former Head of Digital Platforms, HarperCollins Publishers